EM
Eliana Merle UBS Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Monte Rosa Therapeutics
GLUE
$305M
| $4.94 | $22 |
345%
upside
| Buy | 2 years ago |
|
27
Regenxbio
RGNX
$490M
| $9.71 | $47 |
384%
upside
| Buy | 3 years ago |
|
28
Amicus Therapeutics
FOLD
$2.46B
| $7.99 | $16 |
100%
upside
| Buy | 4 years ago |
|
29
Galapagos
GLPG
$2.2B
| $33.36 | $134 |
302%
upside
| Neutral | 5 years ago |
|
|
30
Amicus Therapeutics
FOLD
$2.46B
| $7.99 | $20 |
150%
upside
| Overweight | 5 years ago |
|